Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Leonie Bruine de Bruin, Jan E. Wachters, Michiel L. Schrijvers, Lorian Slagter‐Menkema, Mirjam F. Mastik, Johannes A. Langendijk, Jacqueline E. van der Wal, Ed Schuuring & Bernard F. A. M. van der Laan. (2019) PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy. Laryngoscope Investigative Otolaryngology 4:4, pages 399-404.
Crossref
Crossref
Francesco Perri, Franco Ionna, Paolo Muto, Massimiliano Di Marzo, Francesco Caponigro, Francesco Longo, Giuseppina Della Vittoria Scarpati, Giuseppe Di Lorenzo, Mario Giuliano & Raffaele Solla. (2019) Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy. Future Science OA 5:1.
Crossref
Crossref
Daniela Alterio, Giulia Marvaso, Fausto Maffini, Sara Gandini, Susanna Chiocca, Annamaria Ferrari, Lorenzo Preda, Maria Cossu Rocca, Daniela Lepanto, Cristiana Fodor, Stefania Volpe, Samantha Dicuonzo, Antonio Laudati, Gioacchino Giugliano, Mohssen Ansarin & Barbara A. Jereczek-Fossa. (2017) Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression. Medical Oncology 34:6.
Crossref
Crossref
Chloé Rancoule, Jean-Baptiste Guy, Alexis Vallard, Majed Ben Mrad, Amel Rehailia & Nicolas Magné. (2017) Les 50 ans du cisplatine. Bulletin du Cancer 104:2, pages 167-176.
Crossref
Crossref
Paolo Bossi, Carlo Resteghini, Nicholas Paielli, Lisa Licitra, Silvana Pilotti & Federica Perrone. (2016) Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget 7:45, pages 74362-74379.
Crossref
Crossref
Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, Jean-Marie Stephan & Kimberly K. Leslie. (2014) Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers. Molecular Diagnosis & Therapy 18:2, pages 137-151.
Crossref
Crossref
Pernille Lassen, Jens Overgaard & Jesper Grau Eriksen. (2013) Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: Correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials. Radiotherapy and Oncology 108:3, pages 489-494.
Crossref
Crossref
C.S. Scanlon, E.A. Van Tubergen, R.C. Inglehart & N.J. D’Silva. (2012) Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma. Journal of Dental Research 92:2, pages 114-121.
Crossref
Crossref
Piernicola Pedicini, Antonio Nappi, Lidia Strigari, Barbara Alicia Jereczek-Fossa, Daniela Alterio, Marta Cremonesi, Francesca Botta, Barbara Vischioni, Rocchina Caivano, Alba Fiorentino, Giuseppina Improta, Giovanni Storto, Marcello Benassi, Roberto Orecchia & Marco Salvatore. (2012) Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma. Radiation Oncology 7:1.
Crossref
Crossref
Piernicola Pedicini, Rocchina Caivano, Barbara Alicia Jereczek-Fossa, Lidia Strigari, Barbara Vischioni, Daniela Alterio, Marta Cremonesi, Francesca Botta, Antonio Nappi, Giuseppina Improta, Giovanni Storto, Marcello Benassi & Roberto Orecchia. (2012) Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theoretical Biology and Medical Modelling 9:1.
Crossref
Crossref
Ilse J. Hoogsteen, Henri A.M. Marres, Franciscus J.A. van den Hoogen, Paul F.J.W. Rijken, Jasper Lok, Johan Bussink & Johannes H.A.M. Kaanders. (2012) Expression of EGFR Under Tumor Hypoxia: Identification of a Subpopulation of Tumor Cells Responsible for Aggressiveness and Treatment Resistance. International Journal of Radiation Oncology*Biology*Physics 84:3, pages 807-814.
Crossref
Crossref
Adrian C. Begg. (2012) Predicting Recurrence After Radiotherapy in Head and Neck Cancer. Seminars in Radiation Oncology 22:2, pages 108-118.
Crossref
Crossref
Juliette Thariat, Marie-Christine Etienne-Grimaldi, Dominique Grall, René-Jean Bensadoun, Anne Cayre, Frédérique Penault-Llorca, Laurence Veracini, Mireille Francoual, Jean-Louis Formento, Olivier Dassonville, Dominique De Raucourt, Lionel Geoffrois, Philippe Giraud, Séverine Racadot, Sylvain Morinière, Gérard Milano & Ellen Van Obberghen-Schilling. (2012) Epidermal Growth Factor Receptor Protein Detection in Head and Neck Cancer Patients: A Many-Faceted Picture. Clinical Cancer Research 18:5, pages 1313-1322.
Crossref
Crossref
Carmen Holz, Franziska Niehr, Mariya Boyko, Tsvetana Hristozova, Luitpold Distel, Volker Budach & Ingeborg Tinhofer. (2011) Epithelial–mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells. Radiotherapy and Oncology 101:1, pages 158-164.
Crossref
Crossref
Aristeidis Chrysovergis, Vasilios G. Gorgoulis, Ioannis Giotakis, Evangelos Tsiambas, Andreas Karameris, Christos Kittas & Aspasia Kyroudi. (2010) Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis. Medical Oncology 28:3, pages 871-877.
Crossref
Crossref
Rafal Suwinski, Magdalena Jaworska, Barbara Nikiel, Wozniak Grzegorz, Magdalena Bankowska-Wozniak, Majewski Wojciech, Skladowski Krzysztof & Lange Dariusz. (2010) Predicting the Effect of Accelerated Fractionation in Postoperative Radiotherapy for Head and Neck Cancer Based on Molecular Marker Profiles: Data From a Randomized Clinical Trial. International Journal of Radiation Oncology*Biology*Physics 77:2, pages 438-446.
Crossref
Crossref
Michael I. Koukourakis, Pelagia G. Tsoutsou, Antonios Karpouzis, Maria Tsiarkatsi, Ilias Karapantzos, Vassilios Daniilidis & Constantinos Kouskoukis. (2010) Radiochemotherapy With Cetuximab, Cisplatin, and Amifostine for Locally Advanced Head and Neck Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics 77:1, pages 9-15.
Crossref
Crossref
Quynh-Thu Le & Jiade J. Lu. 2010. Nasopharyngeal Cancer. Nasopharyngeal Cancer
27
40
.
C M West, L Joseph & S Bhana. (2008) Epidermal growth factor receptor-targeted therapy. The British Journal of Radiology 81:special_issue_1, pages S36-S44.
Crossref
Crossref
M. Rafferty, T.R. Helliwell, D.J. Husband, J. Fenton, T.M. Jones & A.S. Jones. (2008) Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx. Oral Oncology 44:10, pages 975-981.
Crossref
Crossref
Rob Glynne-Jones & Peter Hoskin. (2007) Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?. Journal of Clinical Oncology 25:33, pages 5281-5286.
Crossref
Crossref
M. Pruschy. (2007) Neue Konzepte und Substanzen zur RadiosensibilisierungNew concepts and substances for radiosensitization. Der Onkologe 13:3, pages 263-268.
Crossref
Crossref